Cancer & Disease Research
Tumor-promoting mutation linked to suppression of anticancer immune response
Mutations that support the growth of tumor cells may also inhibit T cells, preventing the immune system from responding effectively to emerging cancers, according to Harvard Medical School researchers. Read More
Nanoparticles enhance effect of brain stimulation on stroke recovery in rats
Combining nasally administered nanoparticles and noninvasive brain stimulation improves the recovery of ischemic stroke in rats, according to researchers from Xi’an Jiaotong-Liverpool University and other universities in China. Read More
Biotech licenses drug discovery platform from Harvard, Tufts to study complex CNS diseases
Unravel Biosciences has licensed a drug discovery platform from Harvard University and Tufts University to decode and model complex central nervous system (CNS) diseases. Read More
CRISPR edited rat embryos reveal cause of rare pediatric neurodegenerative disease
Using CRISPR gene editing technology on rat embryos, University of Wisconsin-Madison researchers have revealed the mutation that is responsible for progressive gait abnormalities and other symptoms in human infants and young children with a rare neurodegenerative disease. Read More
New AI tool discovers mutations linking bladder cancer to tobacco smoking
Using a new artificial intelligence (AI) tool, University of California, San Diego researchers contend they have for the first time uncovered a pattern of DNA mutations that links bladder cancer to tobacco smoking. Read More
NIH funds repurposing of breast cancer drug against glioblastoma
The National Institutes of Health (NIH) is funding research into the repurposing of the breast cancer drug letrozole for use against the most deadly form of brain tumors. Read More
Mutated mitochondrial microprotein linked to increased risk of Alzheimer’s
University of Southern California researchers have linked a mitochondrial DNA variant to increased risk of Alzheimer’s disease, pointing to a new way to tackle the hard-to-treat condition. Read More
Combination therapy improves survival in mice with deadly glioblastoma
Combining an antidepressant and vascular endothelial growth factor inhibitor improves outcomes in mouse models of a hard-to-treat type of brain cancer, despite neither treatment being efficacious as a single agent, according to new research. Read More
Boosting TERRA levels damages DNA of hard-to-kill cancer cells: study
Increasing levels of telomeric repeat-containing RNA (TERRA) damages the DNA of cancers with a particular form of replicative immortality and leads to cell death, according to Portuguese researchers who show that “anti-aging clocks” can be used to kill cancer cells. Read More
Researchers further understanding of how circadian clock helps brain recover after injury
Children’s National Hospital researchers have found that a relatively newly discovered type of brain cell -- known as NG2-glia -- also follows a circadian rhythm, findings that potentially open new paths of investigation for the development of future traumatic brain injury therapies. Read More
Conferences
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter